Results 41 to 50 of about 55,585 (303)

Neuropsychiatric disturbances in atypical Parkinsonian disorders [PDF]

open access: yes, 2018
Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system ...
Belvisi, Daniele   +6 more
core   +1 more source

A Comparison of the Neuroprotective and Reactivating Efficacy of a Novel Bispyridinium Oxime K870 with Commonly Used Pralidoxime and the Oxime HI-6 in Tabun-Poisoned Rat

open access: yesActa Medica, 2021
Aim: The comparison of neuroprotective and central reactivating effects of the oxime K870 in combination with atropine with the efficacy of standard antidotal treatment in tabun-poisoned rats.
Jiří Kassa   +5 more
doaj   +1 more source

Coronary angiography in heart failure: when and why? Uncertainty reigns [PDF]

open access: yes, 2017
No abstract ...
Petrie, Mark C., Rocchiccioli, Paul
core   +1 more source

Measures of physical performance in COVID-19 patients: a mapping review

open access: yesPulmonology, 2021
Background and objective There is evidence of short- and long-term impairment of physical performance in patients with COVID-19 infection, but a verification of measures of physical impairment in this condition is lacking.
Carla Simonelli   +3 more
doaj   +3 more sources

Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies [PDF]

open access: yes, 2010
In recent years there has been a rapid growth of interest in exploring the relationship between nutritional therapies and the maintenance of cognitive function in adulthood.
Anderson   +28 more
core   +1 more source

Neuroprotective Effects of Antidotes in Soman-Poisoned Rats

open access: yesActa Medica, 1999
1. The neuroprotective effects of antidotes (atropine, obidoxime/atropine mixture, HI-6/atropine mixture) on rats poisoned with soman at a sublethal dose (48 μg/kg i.m.; 60% of LD50 value) were studied.
Jiří Kassa, Marie Koupilová
doaj   +1 more source

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment Design and Cohort Baseline Characteristics of the German Dementia Competence Network [PDF]

open access: yes, 2009
Background: The German Dementia Competence Network (DCN) has established procedures for standardized multicenter acquisition of clinical, biological and imaging data, for centralized data management, and for the evaluation of new treatments.
Frölich, Lutz   +21 more
core   +1 more source

Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz   +3 more
wiley   +1 more source

Ninety-day oral toxicity study of rice-derived γ-oryzanol in Sprague-Dawley rats

open access: yesToxicology Reports, 2017
A 90-day oral toxicity study of γ-oryzanol, a rice-derived triterpenoid ferulate, was performed by oral gavage administration to male and female Sprague-Dawley rats at doses of 0, 1000, and 2000 mg/kg body weight/day.
Seol-Hee Moon   +5 more
doaj   +1 more source

Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoids and terpenes derived from Cannabis sativaL

open access: yesHeliyon, 2023
HempChoice® Hemp Oil Extract (Geocann, LLC) is an extract of the aerial parts of hemp (Cannabis sativa L.) primarily comprised of 55–75% cannabidiol (CBD), 1–15% other phytocannabinoids and 1–15% terpenes.
Margitta Dziwenka   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy